The combined effect of albuminuria and inflammation on all-cause and cardiovascular mortality in nondiabetic persons

Journal of Internal Medicine

Volumn 264, Issue 5, 2008, Pages 493-501

  Jorgensen L ^a   Jenssen, T ^a,b   Heuch, I ^c   Jacobsen, B K ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Albuminuria; Epidemiology; Inflammation; Mortality

Indexed keywords

ALBUMIN; CREATININE; FIBRINOGEN;

ADULT; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CELL COUNT; CREATININE URINE LEVEL; DISEASE MARKER; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CREATININE; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LINEAR MODELS; MALE; MIDDLE AGED; NORWAY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 53549096518     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01992.x     Document Type: Article

References (21)

1. Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004 17 : 986 93.
2. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003 108 : 2154 69.
3. Arnlov J, Evans JC, Meigs JB et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005 112 : 969 75.
4. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001 286 : 421 6.
5. Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002 106 : 1777 82.
6. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004 110 : 32 5.
7. Romundstad S, Holmen J, Kvenild K, Hallan H, Ellekjær H. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway. Am J Kidney Dis 2003 42 : 466 73.
8. Yuyun MF, Khaw KT, Luben R et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol 2004 33 : 189 98.
9. Pedrinelli R, Dell'Omo G, Di Bello V et al. Low-grade inflammation and microalbuminuria in hypertension. Arterioscler Thromb Vasc Biol 2004 24 : 2414 9.
10. Stuveling EM, Bakker SJ, Hillege HL et al. C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension 2004 43 : 791 6.
11. Jørgensen L, Jenssen T, Johnsen SH et al. Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: the Tromsø Study. Eur Heart J 2007 28 : 363 9.
12. Jørgensen L, Singh K, Berntsen GK, Jacobsen BK. A population-based study of the prevalence of abdominal aortic aneurysms in relation to bone mineral density. The Tromsø study. Am J Epidemiol 2005 159 : 945 9.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 70.
14. Johnsen SH, Fosse E, Joakimsen O et al. Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromsø Study. Stroke 2005 36 : 715 9.
15. Bruno G, Merletti F, Biggeri A et al. Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia 2005 48 : 427 34.
16. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999 340 : 115 26.
17. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004 21 (Suppl. 1 II2 10.
18. Fried L, Solomon C, Shlipak M et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 2004 15 : 3184 91.
19. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002 62 : 963 70.
20. World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Geneva : World Health Organization, 1999.
21. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006 116 : 1793 801.